Bradley Foster & Sargent’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.4M Buy
627,470
+134,550
+27% +$10.8M 0.61% 44
2025
Q4
$47M Buy
492,920
+39,056
+9% +$3.83M 0.69% 40
2025
Q3
$44.3M Sell
453,864
-100,560
-18% -$10.4M 0.65% 43
2025
Q2
$59.6M Sell
554,424
-8,670
-2% -$877K 0.93% 30
2025
Q1
$56.8M Sell
563,094
-15,843
-3% -$1.6M 0.97% 31
2024
Q4
$51.7M Sell
578,937
-7,271
-1% -$640K 0.87% 31
2024
Q3
$49.1M Sell
586,208
-82,188
-12% -$6.48M 0.82% 34
2024
Q2
$51.5M Sell
668,396
-4,234
-0.6% -$310K 0.93% 33
2024
Q1
$46.1M Sell
672,630
-2,366
-0.4% -$152K 0.83% 37
2023
Q4
$39M Buy
674,996
+15,718
+2% +$839K 0.76% 41
2023
Q3
$35.7M Hold
659,278
0.75% 41
2023
Q2
$35.7M Sell
659,278
-183,886
-22% -$9.6M 0.75% 41
2023
Q1
$42.2M Buy
843,164
+4,742
+0.6% +$223K 1.01% 30
2022
Q4
$38.8M Buy
838,422
+2,549
+0.3% +$110K 0.97% 33
2022
Q3
$32.4M Buy
835,873
+5,178
+0.6% +$208K 0.9% 35
2022
Q2
$31M Sell
830,695
-8,519
-1% -$347K 0.8% 42
2022
Q1
$37.2M Buy
+839,214
New +$36.4M 0.79% 39

Other funds holding BSX